Home/Filings/4/0001567619-20-020709
4//SEC Filing

Peterson Amy C. 4

Accession 0001567619-20-020709

CIK 0001501989other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:59 PM ET

Size

4.8 KB

Accession

0001567619-20-020709

Insider Transaction Report

Form 4
Period: 2020-11-30
Peterson Amy C.
EVP, Chief Development Officer
Transactions
  • Award

    Common Stock

    2020-11-30$6.39/sh+3,101$19,8223,101 total
Footnotes (1)
  • [F1]3,101 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001682735

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:59 PM ET
Size
4.8 KB